Bluebook
Pharma Services: Drug Development June 2024
2024 - June: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
Highlights from this edition:
- Pro-Ficiency Holdings was acquired by Simulations Plus, Inc. (NasdaqGS:SLP)
- Integral Diagnostics Limited (ASX:IDX) announced its acquisition of Capitol Health Limited (ASX:CAJ)
- Trialspark closed a $372MM Series A Financing, led by Sequoia Capital Operations LLC, Sanofi (ENXTPA:SAN), Andreessen Horowitz LLC, SV Angel, Thrive Capital Management, LLC, Emerson Collective, LLC, FPV Ventures, LLC